BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Ellman International, Inc. Announces Executive Team Hire


9/3/2010 10:14:38 AM

OCEANSIDE, N.Y., Sept. 1 /PRNewswire/ -- Ellman International, Inc., a New York based developer, manufacturer and marketer of RF devices for surgical and aesthetic procedures, announced that Frank D. D'Amelio will join its executive team in the position of Chief Operating Officer (COO), Executive Vice President. "We are proud to welcome Mr. D'Amelio, a senior medical device professional who will help guide the company's continued growth," said Chief Executive Officer Rick Epstein.

Innovation and aggressive new product development will mark the next phase for Pelleve and Ellman International. "Frank's extensive experience in developing strong global strategic alliances will be invaluable as we seek new breakthrough technologies to reinforce our versatility in surgical and non-surgical aesthetic systems," said Mr. Epstein.

D'Amelio brings over 25 years of executive experience in the areas of worldwide business development, manufacturing and operations, and the strategic research and development portfolio management. Most recently, he served as the President of LTC Technologies, a bipolar tissue sealing and welding company and was the former Chief Technology Officer of Gyrus/ACMI, a leading global medical visualization and surgical energy company. At Gyrus/ACMI, Mr. D'Amelio developed and launched numerous endoscopic and electrosurgical systems for the GI, general surgery, urology and gynecology markets and formed a number of significant strategic alliances with other medical device companies. He is a named inventor of approximately 40 worldwide issued or pending patents.

"As we plan for continued growth, we need strong, globally experienced medical device leaders. Frank will complement our already diverse & dynamic sales and marketing leadership teams," added Epstein.

"Ellman International and Pelleve are well positioned and offer a great platform for both internal development of new leading edge products and properly structured strategic alliances. I look forward to working with the marketing, sales and financial teams at Ellman to bring these products and services to the market," said D'Amelio.

For more information, visit www.ellman.com and www.pelleve.com.

About Ellman International

Established in 1959, Ellman International (Oceanside, New York) is a privately held developer, manufacturer and marketer of medical devices for surgical procedures requiring cutting, coagulating, and tissue ablation. A trusted leader in high frequency radiowave energy sources, Ellman's advanced technologies offer unique versatility and precision to the surgical and aesthetic markets. In 2008, Baird Capital Partners and an investment group, which includes Ellman's senior executives, acquired Ellman.

The company's proven product platform includes the SurgitronĀ® Dual RF S5, which provides patented 4.0 MHz energy delivery for maximum control in precision cutting, with more versatility than other technologies in the office and clinic environments. The Dual RF S5 also powers the Pelleve Wrinkle Reduction System, the innovative, FDA-cleared skin tightening system for nonablative wrinkle treatment. Pelleve safely treats facial wrinkles without surgery by improving skin firmness for a naturally refreshed appearance. For more information, please visit www.ellman.com and www.pelleve.com.

SOURCE Ellman International, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES